Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients
Retrospective Data Analysis in Chronic Prostatitis/Chronic Pelvic Pain Syndrome Patients: Evaluation of the Relationship Between Presence of Microorganism and Severity of Symptom
1 other identifier
observational
112
1 country
1
Brief Summary
Chronic prostatitis/chronic pelvic pain syndrome (CPPS) is a common health problem among men and can cause severe quality of life. The pathophysiology of CPPS is still poorly understood and effective treatments are a challenging issue. This study aims to investigate the possible relationship between the presence of microorganisms in the prostatic fluid and symptom severity by presenting a retrospective analysis based on data from CPPS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2023
CompletedFirst Submitted
Initial submission to the registry
August 16, 2023
CompletedFirst Posted
Study publicly available on registry
August 29, 2023
CompletedAugust 29, 2023
August 1, 2023
3 years
August 16, 2023
August 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Correlation between androflor pcr positive patients and uopint and nih-cpsi
Those with positive and negative Androflor PCR test will be evaluated. testicular torsion
2 years
Study Arms (1)
singel
Interventions
Chronic prostatitis/chronic pelvic pain syndrome UPOINT
Eligibility Criteria
This study is based on data from 112 CPPS patients aged 20-60 years. Various variables such as demographic information of the patients, International Prostate Symptom Score (I-PSS), which evaluates CPPS symptoms, inflammatory and non-inflammatory symptoms of CPPS, baseline scores of the International Index of Erectile Function (IIEF), which evaluates erectile function, and the presence of microorganisms in the prostate fluid were analyzed retrospectively.
You may qualify if:
- Patients who were diagnosed with chronic prostatitis/chronic pelvic pain syndrome and whose prostate fluid was taken with prostate massage and androflor testis were studied were included.
You may not qualify if:
- acute and/or chronic bacterial prostatitis, active history of genitourinary cancer, history of recent prostate surgery the diagnosis of neurological diseases affecting the bladder was determined
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hisar Intercontinental Hospital
Istanbul, 34768, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass. Prof.
Study Record Dates
First Submitted
August 16, 2023
First Posted
August 29, 2023
Study Start
January 1, 2020
Primary Completion
December 31, 2022
Study Completion
May 10, 2023
Last Updated
August 29, 2023
Record last verified: 2023-08